Today’s Times (Dec. 12, 2009, page 1) has “Poor Children Likelier to Get Antipsychotics” opens with:
“Now federal financed drug research reveals a stark disparity: children covered by Medicaid are given powerful antipsychotic medicines at a rate four times higher than children whose parents have private insurance.”
The rest is summarizing detail: More drugs for less severe conditions, conditions that are controlled without drugs by middle class parents. Severe physical side effects from the drugs. But never mind. A group of medical doctors in 16 states has formed an organization, “Too Many, Too Much, Too Young” and they are ignored. Health Affairs will publish the federally financed research early next year. A “stunning disparity,” doctors say.
The reason is insurance reimbursements: costly (via Medicaid) but cheaper than counseling. The easiest justification is “bipolar disorder.” What is that? Medicaid without co-pay pays for the drugs, which cost up to $400/month. These drugs are the single biggest expenditure for Medicaid. The kids are age 3 to 17. They are often “off label” prescriptions (without FDA approval). Once on the drugs, some parents report comments like “It is impossible to stop now.”
Get the picture?
This has been going on for several years. And, please, we do not give a shit about the cost. After our deficit terrorists, who always declare “We cannot afford it, whatever it is!,” have had their say the responsible (independent) apologists puts it this way: “Medicaid kids are subject to a lot of stresses that lead to behavior issues which can be hard to distinguish from more serious psychiatric conditions.”
Do you smell stink of pitch in that remark? The non-apologists point out that “a lot of these kids are not getting any other mental health services.”
We are talking schizophrenia, autism, and bipolar disorder. All of these diagnostic categories are questionable; even the related more minor diagnoses (attention deficit, hyperactivity, persistent defiance, etc.) are included when Medicaid, with its big bucks, is involved. .
The structure of this drug pushing is, as you might expect, profit driven. Profit-driven corporations who produce these drugs are a monopoly (Pfizer, GlaxoSmithKline, Sanoff-Aventis, Johnson & Johnson, Merk, Novartis, AstraZeneca). Shame on them. They employ thousands—actually thousands, no exaggeration, of well-paid lobbyists—to pressures legislators, legislative staff, Medicaid and FDA official’s staff, and “opinion leaders,” to promote these drug buys. These thousands of corrupted salesmen are good at what they do. They are smart enough to reach the neighborhood poverty docs and the docs working for peanuts in the hinterlands.
I wanted to share this with you, a piece of everyday intelligence.
Jim